Published in Medical Letter on the CDC and FDA, December 25th, 2005
The evaluation method that may lead to exploring development of special vaccines using new techniques, which may be more effective against new strains of viruses. Current techniques are dependent upon developing vaccines from cultures of a weakened pathogen, which can still result in the development of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.